BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shan L, Liu Z, Ci L, Shuai C, Lv X, Li J. Research progress on the anti-hepatic fibrosis action and mechanism of natural products. Int Immunopharmacol 2019;75:105765. [PMID: 31336335 DOI: 10.1016/j.intimp.2019.105765] [Cited by in Crossref: 10] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Yan J, Feng Y, Fang X, Cui X, Xia X, Li F, Luo W, Liang J, Feng J, Yu K. Anti-liver fibrosis effects of the total flavonoids of litchi semen on CCl4-induced liver fibrosis in rats associated with the upregulation of retinol metabolism. Pharm Biol 2022;60:1264-77. [PMID: 35787093 DOI: 10.1080/13880209.2022.2086584] [Reference Citation Analysis]
2 Li W, Liu W, Qian D, Liu J, Zhou S, Zhang L, Peng W, Su L, Zhang H. Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis. Front Pharmacol 2022;13:962525. [DOI: 10.3389/fphar.2022.962525] [Reference Citation Analysis]
3 Hong B, Wang Y, Hou Y, Liu R, Li W. Study on the mechanism of anti-hepatic fibrosis of Glycyrrhiza Uralensis-Salvia miltiorrhiza prescription based on serum and urine metabolomics and network pharmacology. J Chromatogr B Analyt Technol Biomed Life Sci 2022;1209:123416. [PMID: 36027704 DOI: 10.1016/j.jchromb.2022.123416] [Reference Citation Analysis]
4 Wang H, Ma J, Zhou M, Si J, Cui B. Current advances and potential trends of the polysaccharides derived from medicinal mushrooms sanghuang. Front Microbiol 2022;13:965934. [DOI: 10.3389/fmicb.2022.965934] [Reference Citation Analysis]
5 Amer MA, Othman AI, El-Missiry MA, Farag AA, Amer ME. Proanthocyanidins attenuated liver damage and suppressed fibrosis in CCl4-treated rats. Environ Sci Pollut Res Int 2022. [PMID: 35881285 DOI: 10.1007/s11356-022-22051-7] [Reference Citation Analysis]
6 Zhang CY, Hu XC, Zhang GZ, Liu MQ, Chen HW, Kang XW. Role of Nrf2 and HO-1 in intervertebral disc degeneration. Connect Tissue Res 2022;:1-18. [PMID: 35736364 DOI: 10.1080/03008207.2022.2089565] [Reference Citation Analysis]
7 Zhang Q, Luo P, Zheng L, Chen J, Zhang J, Tang H, Liu D, He X, Shi Q, Gu L, Li J, Guo Q, Yang C, Wong YK, Xia F, Wang J. 18beta-Glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs. Journal of Pharmaceutical Analysis 2022. [DOI: 10.1016/j.jpha.2022.06.001] [Reference Citation Analysis]
8 Zhou M, Zhao X, Liao L, Deng Y, Liu M, Wang J, Xue X, Li Y. Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS. Oxid Med Cell Longev 2022;2022:9938392. [PMID: 35035671 DOI: 10.1155/2022/9938392] [Reference Citation Analysis]
9 Wang F, Zhou J, Chen E. Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis. Front Pharmacol 2022;13:787748. [DOI: 10.3389/fphar.2022.787748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cheng J, Chen Z, Zuo G, Cao W. Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis. J Int Med Res 2022;50:3000605221074525. [PMID: 35086375 DOI: 10.1177/03000605221074525] [Reference Citation Analysis]
11 Liu F, Sun C, Chen Y, Du F, Yang Y, Wu G. Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway. J Clin Transl Hepatol 2021;9:917-30. [PMID: 34966655 DOI: 10.14218/JCTH.2021.00032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Jia W, Liang S, Cheng B, Ling C. The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment. Front Oncol 2021;11:763519. [PMID: 34868982 DOI: 10.3389/fonc.2021.763519] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Ma Y, Du X, Zhao D, Tang K, Wang X, Guo S, Li X, Mei S, Sun N, Liu J, Jiang C. 18:0 Lyso PC, a natural product with potential PPAR-γ agonistic activity, plays hypoglycemic effect with lower liver toxicity and cardiotoxicity in db/db mice. Biochem Biophys Res Commun 2021;579:168-74. [PMID: 34607170 DOI: 10.1016/j.bbrc.2021.09.059] [Reference Citation Analysis]
14 Yin K, Li X, Luo X, Sha Y, Gong P, Gu J, Tan R. Hepatoprotective Effect and Potential Mechanism of Aqueous Extract from Phyllanthus emblica on Carbon-Tetrachloride-Induced Liver Fibrosis in Rats. Evid Based Complement Alternat Med 2021;2021:5345821. [PMID: 34712342 DOI: 10.1155/2021/5345821] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Chen HW, Zhang GZ, Liu MQ, Zhang LJ, Kang JH, Wang ZH, Liu WZ, Lin AX, Kang XW. Natural Products of Pharmacology and Mechanisms in Nucleus Pulposus Cells and Intervertebral Disc Degeneration. Evid Based Complement Alternat Med 2021;2021:9963677. [PMID: 34394398 DOI: 10.1155/2021/9963677] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Huang J, Li Y, Xu D, Zhang X, Zhou X. RUNX1 regulates SMAD1 by transcriptionally activating the expression of USP9X, regulating the activation of hepatic stellate cells and liver fibrosis. Eur J Pharmacol 2021;903:174137. [PMID: 33933467 DOI: 10.1016/j.ejphar.2021.174137] [Reference Citation Analysis]
17 Qin LJ, Lu Z, Zheng ZH, Zhong XH. Research progress of natural products interfering with cell signaling pathway in liver fibrosis. J Asian Nat Prod Res 2021;:1-10. [PMID: 33779429 DOI: 10.1080/10286020.2021.1883003] [Reference Citation Analysis]
18 Wei F, Zhang X, Cui P, Gou X, Wang S. Cell-based 3D bionic screening by mimicking the drug-receptor interaction environment in vivo. J Mater Chem B 2021;9:683-93. [PMID: 33367374 DOI: 10.1039/d0tb02661a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ma X, Jiang Y, Wen J, Zhao Y, Zeng J, Guo Y. A comprehensive review of natural products to fight liver fibrosis: Alkaloids, terpenoids, glycosides, coumarins and other compounds. Eur J Pharmacol 2020;888:173578. [PMID: 32976828 DOI: 10.1016/j.ejphar.2020.173578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
20 Ma X, Tang M, Lu L, Zheng J, Huang J, Li J, Luo W. Effects of salvianolic acid B on liver fibrosis: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e21036. [PMID: 32664111 DOI: 10.1097/MD.0000000000021036] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Shen C, Huang XY, Geng CA, Li TZ, Tang S, Su LH, Gao Z, Zhang XM, Hu J, Chen JJ. Artemlavanins A and B from Artemisia lavandulaefolia and Their Cytotoxicity Against Hepatic Stellate Cell Line LX2. Nat Prod Bioprospect 2020;10:243-50. [PMID: 32583278 DOI: 10.1007/s13659-020-00254-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Jiang J, Wang F, Luo A, Lin S, Feng X, Yan W, Shi Y, Zhang Q, Gu X, Cui G, Wang J, Wang L, Zhang Q, Tan W. Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-β/Smad2/3 Pathway. Front Pharmacol 2020;11:767. [PMID: 32528292 DOI: 10.3389/fphar.2020.00767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
23 Wu H, Chen G, Wang J, Deng M, Yuan F, Gong J. TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1/Mitophagy signalling pathway. Cell Prolif. 2020;53:e12731. [PMID: 31755616 DOI: 10.1111/cpr.12731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]